2Tanaka Y,Hasegawa I,Kato T,et al.A case-control study for differences among hepatitis B virus infections of genotypes A (subtypes Aa and Ae) and D Hepatology,2004,40:747-755. 被引量：1
3Ahn SH,Kramvis A,Kawai S,et al.Sequence variation upstream of precore translation initiation codon reduces hepatitis B virus e antigen production.Gastroenterology,2003,125:1370-1378. 被引量：1
4Lok AS,Heathcote EJ,Hoofnagle JH.Management of hepatitis B:2000 summary of a workshop.Gastroenterology,2001,120:1828 -1853. 被引量：1
5Sanchez TJM,Costa J,Mas A,et al.Influence of hepatitis B virus genotype on the long-termoutcome of chronic hepatitis B in western patients.Gastroenterology,2002,123:1848-1856. 被引量：1
6Bartholomeusz A,Schaefer S.Hepatitis B virus genotypes:comparison of genotyping methods.Reviews in Medical Virology,2004,14:3-16. 被引量：1
7Fujie H,Moriya K,Shintani Y,et al.Hepatitis B virus genotypes and hepatocellular carcinoma in Japan.Gastroenterology,2001,120:1564-1565. 被引量：1
8Orito E,Ichida T,Sakugawa H,et al.Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan.Hepatology,2001,34:590-594. 被引量：1
9Kao J H,Chen DS.Hepatitis B virus genotypes and core promoter variant.Gastroenterology,2004,126:633. 被引量：1
10Orito E,Mizokami M,Sakugawa H,et al.A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C.Japan HBV Genotype Research Group.Hepatology,2001,33:218-223. 被引量：1
3Deguchi M,Yamashita N,Kagita M,et al.Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay[J].J Virol Methods,2004,115(2):217-222. 被引量：1
4Kohmoto M,Enomoto M,Tamori A,et al.Quantitative detection of hepatitis B surface antigen by chemiluminescent microparticle immunoassay during lamivudine treatment of chronic hepatitis B virus carriers[J].J Med Virol,2005,75(2):235-239. 被引量：1
5Kittner JM,Sprinzl MF,Grambihler A,et al.Adding pegylated interferon to a current nucleos(t)ide therapy leads to HBs Ag seroconversion in a subgroup of patients with chronic hepatitis B[J].J Clin Virol,2012,54(1):93-95. 被引量：1
6Wang XY,Zhang XX,Yao X,et al.Serum HBe Ag sero-conversion correlated with decrease of HBs Ag and HBV DNA in chronic hepatitis B patients treated with a therapeutic vaccine[J].Vaccine,2010,28(51):8169-8174. 被引量：1
7Ozaras R,Tabak F,Tahan V,et al.Correlation of quantitative assay of HBs Ag and HBV DNA levels during chronic HBV treatment[J].Dig Dis Sci,2008,53(11):2995-2998. 被引量：1
8Ganji A,Esmaeilzadeh A,Ghafarzadegan K,et al.Correlation between HBs Ag quantitative assay results and HBV DNA levels in chronic HBV[J].Hepat Mon,2011,11(5):342-345. 被引量：1
9Gupta E,Kumar A,Choudhary A,et al.Serum hepatitis B surface antigen levels correlate with high serum HBV DNA levels in patients with chronic hepatitis B:a cross-sectional study[J].Indian J Med Microbiol,2012,30(2):150-154. 被引量：1
10Thompson AJ,Nguyen T,Iser D,et al.Serum hepatitis B surface antigen and hepatitis B e antigen titers:disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers[J].Hepatology,2010,51(6):1933-1944. 被引量：1
